Form D · Other Technology

BacterioScan, Inc.

St. Louis, MO · CIK 0001577270

Offering snapshot reported Aug 7, 2015 · SEC filing

Reported sold
$1.7M
Offering amount: $4M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 23, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 7, 2015Initial$1,700,305No comparison7SEC filing
Feb 4, 2015Amendment$5,720,000$3,645,000vs May 20, 20137SEC filing
May 20, 2013Initial$2,075,000No comparison20SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-245326
Convertible Promissory Notes

Source: Form D, filed Aug 7, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Moshe Barkan Director
Moshe Barken Director
James R. Brigham, Jr. Director
Jaime De La Zerda Director
Greg Hewett Director
Daniel Hofmann Director
William R. Marshall Director
Dana Marshall Director, Executive
Rhonda Soest Executive
Michael E. Thaman Director, Executive
Richard R. Vietor Director
Amnon Weischelbaum Director
Freddy Zinger Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
4041 Forest Park Ave.
St. Louis, MO, 63108